McDermott + Bull Places Chief Business Officer, Crinetics Pharmaceuticals

McDermott + Bull Places Chief Business Officer, Crinetics Pharmaceuticals

McDermott + Bull has successfully placed Chris Robillard as the Chief Business Officer at Crinetics Pharmaceuticals. Chris will develop, lead, and execute on the company’s business development strategy. He will build global pharmaceutical alliances to maximize the...